Successful “on‐demand” plerixafor for autologous peripheral blood stem‐cells transplantation for relapsed/refractory germ cell tumors

BACKGROUND: Germ cell tumors represent, among solid cancers, a potentially curable disease even if up to 20% to 30% of patients (pts) relapse after first‐line treatment especially considering intermediate and poor prognosis groups. In this scenario, patients are candidates for high‐dose chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Corbingi, Andrea, Metafuni, Elisabetta, Di Salvatore, Mariantonietta, Putzulu, Rossana, Chiusolo, Patrizia, Schinzari, Giovanni, Massini, Giuseppina, Rossi, Ernesto, Zini, Gina, Cassano, Alessandra, Sica, Simona, Piccirillo, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298771/
https://www.ncbi.nlm.nih.gov/pubmed/34822725
http://dx.doi.org/10.1002/jca.21952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298771/
https://www.ncbi.nlm.nih.gov/pubmed/34822725
http://dx.doi.org/10.1002/jca.21952

Ejemplares similares